These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 9047202)
21. Topical platelet-derived growth factor in patients enhances wound closure in the absence of wound contraction. Ehrlich HP; Freedman BM Cytokines Cell Mol Ther; 2002; 7(3):85-90. PubMed ID: 12850807 [TBL] [Abstract][Full Text] [Related]
22. Use of topical recombinant human platelet-derived growth factor BB in abdominal wound separation. Shackelford DP; Fackler E; Hoffman MK; Atkinson S Am J Obstet Gynecol; 2002 Apr; 186(4):701-4. PubMed ID: 11967494 [TBL] [Abstract][Full Text] [Related]
23. Treatment of ischemic wounds using cultured dermal fibroblasts transduced retrovirally with PDGF-B and VEGF121 genes. Breitbart AS; Grande DA; Laser J; Barcia M; Porti D; Malhotra S; Kogon A; Grant RT; Mason JM Ann Plast Surg; 2001 May; 46(5):555-61; discussion 561-2. PubMed ID: 11352431 [TBL] [Abstract][Full Text] [Related]
24. Clinical efficacy of becaplermin (rhPDGF-BB) gel. Becaplermin Gel Studies Group. Wieman TJ Am J Surg; 1998 Aug; 176(2A Suppl):74S-79S. PubMed ID: 9777976 [TBL] [Abstract][Full Text] [Related]
25. [Experimental study on recombinant human platelet-derived growth factor gel in a diabetic rat model of cutaneous incisal wound healing]. Sun TZ; Fu XB; Zhao ZL; Chen W; Sun XQ; Zhou G; Shen ZY Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Oct; 15(10):596-9. PubMed ID: 14552680 [TBL] [Abstract][Full Text] [Related]
26. The effects of platelet-derived growth factor-BB on healing of the rabbit medial collateral ligament. An in vivo study. Hildebrand KA; Woo SL; Smith DW; Allen CR; Deie M; Taylor BJ; Schmidt CC Am J Sports Med; 1998; 26(4):549-54. PubMed ID: 9689377 [TBL] [Abstract][Full Text] [Related]
27. Intravenous curcumin efficacy on healing and scar formation in rabbit ear wounds under nonischemic, ischemic, and ischemia-reperfusion conditions. Jia S; Xie P; Hong SJ; Galiano R; Singer A; Clark RA; Mustoe TA Wound Repair Regen; 2014; 22(6):730-9. PubMed ID: 25230783 [TBL] [Abstract][Full Text] [Related]
28. PDGF and TGF-alpha act synergistically to improve wound healing in the genetically diabetic mouse. Brown RL; Breeden MP; Greenhalgh DG J Surg Res; 1994 Jun; 56(6):562-70. PubMed ID: 8015312 [TBL] [Abstract][Full Text] [Related]
29. The bone marrow-derived endothelial progenitor cell response is impaired in delayed wound healing from ischemia. Bauer SM; Goldstein LJ; Bauer RJ; Chen H; Putt M; Velazquez OC J Vasc Surg; 2006 Jan; 43(1):134-41. PubMed ID: 16414400 [TBL] [Abstract][Full Text] [Related]
30. Reversal of impaired wound healing in irradiated rats by platelet-derived growth factor-BB. Mustoe TA; Purdy J; Gramates P; Deuel TF; Thomason A; Pierce GF Am J Surg; 1989 Oct; 158(4):345-50. PubMed ID: 2508504 [TBL] [Abstract][Full Text] [Related]
31. Collagen-embedded platelet-derived growth factor DNA plasmid promotes wound healing in a dermal ulcer model. Tyrone JW; Mogford JE; Chandler LA; Ma C; Xia Y; Pierce GF; Mustoe TA J Surg Res; 2000 Oct; 93(2):230-6. PubMed ID: 11027465 [TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Wieman TJ; Smiell JM; Su Y Diabetes Care; 1998 May; 21(5):822-7. PubMed ID: 9589248 [TBL] [Abstract][Full Text] [Related]
34. Does becaplermin (platelet-derived growth factor-BB) reverse detrimental effects of ischemia on colonic anastomosis? Saribeyoğlu K; Baca B; Hamzaoğlu I; Pekmezci S; Karahasanoğlu T; Hamzaoğlu H Dis Colon Rectum; 2003 Apr; 46(4):516-20. PubMed ID: 12682547 [TBL] [Abstract][Full Text] [Related]
35. Growth factors and chronic wound healing: past, present, and future. Goldman R Adv Skin Wound Care; 2004; 17(1):24-35. PubMed ID: 14752324 [TBL] [Abstract][Full Text] [Related]
36. Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open-label clinical evaluation of efficacy. Embil JM; Papp K; Sibbald G; Tousignant J; Smiell JM; Wong B; Lau CY Wound Repair Regen; 2000; 8(3):162-8. PubMed ID: 10886806 [TBL] [Abstract][Full Text] [Related]
37. Use of topical recombinant human platelet-derived growth factor-BB (becaplermin) in healing of chronic mixed arteriovenous lower extremity diabetic ulcers. Miller MS J Foot Ankle Surg; 1999; 38(3):227-31. PubMed ID: 10384364 [TBL] [Abstract][Full Text] [Related]
38. Becaplermin gel in the treatment of pressure ulcers: a phase II randomized, double-blind, placebo-controlled study. Rees RS; Robson MC; Smiell JM; Perry BH Wound Repair Regen; 1999; 7(3):141-7. PubMed ID: 10417749 [TBL] [Abstract][Full Text] [Related]
39. The effect of synthetic alginate sulfate hydrogels with recombinant PDGF-BB on Wound healing. Babavalian H; Tebyanian H; Latifi AM; Shokrgozar MA; Bonakdar S; Shakeri F Bratisl Lek Listy; 2018; 119(6):391-396. PubMed ID: 29947241 [TBL] [Abstract][Full Text] [Related]
40. PDGF-BB does not accelerate healing in diabetic mice with splinted skin wounds. Park SA; Raghunathan VK; Shah NM; Teixeira L; Motta MJ; Covert J; Dubielzig R; Schurr M; Isseroff RR; Abbott NL; McAnulty J; Murphy CJ PLoS One; 2014; 9(8):e104447. PubMed ID: 25121729 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]